Takeda Global Oncology Leadership Team
Comprised of Takeda's global oncology commercial operations, Takeda Oncology operates in close alignment with Takeda's dedicated global oncology R&D function, the Oncology Therapeutic Area Unit (OTAU), to address unmet patient needs, move the company's products forward, and to maintain a focus on expanding our oncology pipeline.
Takeda Oncology leadership team is comprised of the following functions and led by the following individuals:
Teresa Bitetti
President
Global Oncology Business Unit
Christopher Arendt, Ph.D.
Head, Oncology Cell Therapy
and Therapeutic Area Unit
Samer Ansari
Head, Digital & IT,
Global Oncology Business Unit
Ana Cardoso
Head, Human Resources
Global Oncology Business Unit
Julie Dixon, Ph.D.
Head, Global Regulatory Affairs
Oncology Business Unit
Awny Farajallah, M.D.
Head, Global Medical Affairs Oncology
Carrie Fernandez
Head, Communications
Global Oncology Business Unit
Stefanie Granado, Ph.D.
Head, EUCAN Oncology Business Unit
Takafumi Horii
Head, Japan Oncology Business Unit
Heather Huet, Ph.D.
Head, Oncology Strategic Operations
Oncology Business Unit
Tetsu Inada
Chief Financial Officer
Global Oncology Business Unit
Liz Lewis
Head, Global Oncology Patient Value,
Policy and Access, Oncology Business Unit
Cristin McArdle
Head Counsel,
Global Oncology Business Unit
Ana Paula Neves
Head, E&C, Global Oncology Business Unit
Rosa Notaroberto
Head, Business Operations,
Global Oncology Business Unit
Dion Warren
Head, US Oncology Business Unit